Background. Glutamine metabolism in fibroblasts is essential for energ
y production, nucleotide biosynthesis, and growth during wound healing
. Because cytokines can impair fibroblast proliferation, we tested the
hypothesis that cytokines impair glutamine metabolism. We studied the
influence of several cytokines on the expression of glutaminase, the
major enzyme of intracellular glutamine metabolism in fibroblasts. Met
hods. Human foreskin fibroblasts were incubated for 6 and 12 hours wit
h varying doses (10, 100, or 1000 units/ml) of interleukin (IL)-1, IL-
6, tumor necrosis factor-alpha, or gamma-interferon. Cell lysates were
assayed for glutaminase-specific activity, and glutaminase protein co
ntent was measured by Western blotting with a polyclonal antibody. Tot
al cellular RNA was extracted, and relative glutaminase messenger RNA
levels were determined by Northern blotting with a P-32-labeled glutam
inase complement DNA-derived probe. These mRNA levels were normalized
by blotting with a beta-actin cDNA-derived probe as control. Cell nucl
ei were isolated, and nuclear run-ons were used to determine relative
glutaminase mRNA transcription rates. Results. IL-1, IL-6, tumor necro
sis factor-alpha, and gamma-interferon decreased glutaminase activity
and protein concentration after a 12-hour incubation in a dose-indepen
dent fashion. No difference was noted at 6 hours. Western blot analysi
s showed a 30% to 60% reduction in glutaminase protein zn treated cell
s. These cytokines also decreased glutaminase mRNA levels, consistent
with transcriptional regulation. This was confirmed by nuclear run-an
assays that showed a decrease in the number of glutaminase transcripts
. Conclusions. A variety of different pro-inflammatory cytokines decre
ase glutaminase expression In cultured human fibroblasts. This cytokin
e-mediated inhibition of glutamine metabolism may limit the availabili
ty of key glutamine-derived intermediates and impair fibroblast prolif
eration in certain patients.